Why Unfractionated Heparin Still Matters in Modern Anticoagulation – Thrombosis Canada
Thrombosis Canada shared a post on LinkedIn:
”Unfractionated heparin has been used for decades.
But using it well still requires careful clinical decisions.
When is UFH preferable to other anticoagulants?
Should treatment begin with a bolus?
When might a no – bolus strategy make more sense?
And how can the risks associated with UFH infusions be reduced?
At Thrombosis Unpacked: Decisions That Matter, Dr. Matthew Nicholson will take a modern look at this familiar anticoagulant in Unfractionated Heparin: Old Drug, Narrow Lane, focusing on where UFH still belongs in clinical practice and strategies to improve its safe use.
Join colleagues from across Canada to explore practical approaches to difficult thrombosis and anticoagulation decisions.
November 7, 2026 | Montréal.‘
Other posts featuring Thrombosis Canada on Hemostasis Today.
-
Sep 29, 2026, 12:02Hajra Malik: Bridging Language Gaps in Hematology With AI
-
Sep 29, 2026, 11:57Joan Montaner: Can Blood Test Identify Intracerebral Hemorrhage Within Minutes?
-
Sep 29, 2026, 11:43From Years Without Answers to Life With Hemophilia Care – WFH
-
Sep 29, 2026, 11:32Sara Al Dallal: Transforming Hemophilia Care Across the Gulf
-
Sep 29, 2026, 11:21Richard Davis: Rapid Rescue in Massive Pulmonary Embolism
-
Sep 29, 2026, 11:14Nissan Brown: Every Step Counts for the Hemophilia Community
-
Sep 29, 2026, 11:03Zain Khalpey: SINGLE AF Adds New Evidence to the Anticoagulation Debate
-
Sep 29, 2026, 10:54How Does Haemophilia Affect Motor Development in Infants? – EAHAD
-
Sep 29, 2026, 10:49Alison Davey: The Vital Role of Community Support in Bleeding Disorders